BIOMARIN PHARMACEUTICAL INC Increase (Decrease) in Asset Retirement Obligations
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Increase (Decrease) in Asset Retirement Obligations of $415.00 thousand for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-10-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAssetRetirementObligations · last filed 2012-10-29
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in asset retirement obligations for the quarter ending 2012-09-30 was $49.00K.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in asset retirement obligations for the quarter ending 2012-06-30 was $322.00K.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in asset retirement obligations for the quarter ending 2012-03-31 was $44.00K.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in asset retirement obligations for the quarter ending 2011-09-30 was $0.00.
| Period end | Increase (Decrease) in Asset Retirement Obligations 3 month | Increase (Decrease) in Asset Retirement Obligations 6 month | Increase (Decrease) in Asset Retirement Obligations 9 month |
|---|---|---|---|
| 2012-09-30 | $49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $371.00K derived: sum of 2 quarters · filed 2012-10-29 | $415.00K 10-Q · filed 2012-10-29 |
| 2012-06-30 | $322.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $366.00K 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $44.00K 10-Q · filed 2012-04-30 | ||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $0.00 derived: sum of 2 quarters · filed 2012-10-29 | $0.00 10-Q · filed 2012-10-29 |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $0.00 10-Q · filed 2012-08-02 | |
| 2011-03-31 | $0.00 10-Q · filed 2012-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |